Intergenus cell fusion between L-form cells of Pseudomonas aeruginosa and Escherichia coli.
Intergenus cell fusion of prokaryotic bacteria was demonstrated for the first time; namely, fusion products doubly resistant to streptomycin and tetracycline were produced by polyethylene glycol treatment of a mixture of the streptomycin-resistant L-form of Pseudomonas aeruginosa and tetracycline-resistant L-form of Escherichia coli.
D002459:Cell Fusion; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000502:physiology*; D011092:Polyethylene Glycols; D011550:Pseudomonas aeruginosa / Q000502:physiology*; D013045:Species Specificity; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D011092:Polyethylene Glycols; D013752:Tetracycline; D013307:Streptomycin